Report Overview: The Global Infectious Disease Diagnostics Market achieved a valuation of $29632.56 Million in 2022 and is anticipated to exceed $49041.76 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 6.5% during the forecast period from 2024 to 2032. Key Market Players: Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher...